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 Uncovering combinatorial interactions in chromatin 
 
Summary. 
It was suggested eighteen years ago that post-translational modifications of specific residues 
in histones could have unique functional roles [1]. A decade ago Brian Strahl and David Allis 
[2] proposed the “histone code” hypothesis – that post-translational modifications on histones 
are read, either individually or in combination, by other proteins to bring about distinct 
downstream events. Since then, much work has focussed on cracking such a code and some 
progress has been made in understanding the roles of some individual modifications. For 
example, the associations between histone acetylation and Histone H3 lysine 4 trimethylation 
(H3K4me3 [3]) with gene expression and H3K9 methylation with gene repression. However 
it has become increasing clear that there is substantial cross-talk between individual 
modifications and between histone modifications and DNA methylation. Development of new 
data sets using whole genome approaches, next generation sequencing and quantitative 
proteomic methods have shed new light on some of the connections between individual 
modifications. These studies are uncovering groups of chromatin modifications associated 
with specific genomic regions. Together such new approaches should help us understand the 
language of epigenetics* .  
* A formal definition of an epigenetic mark is that it is a heritable mark that does not alter the 
DNA sequence. DNA methylation is an epigenetic mark and we understand how the pattern 
of DNA methylation is passed on to daughter cells. Modifications of histone proteins are 
widely referred to as epigenetic marks, though we currently do not understand how such 
modifications may be passed on to daughter cells. Additionally, some modifications play 
transient roles in cellular process such as replication, DNA repair and gene transcription and 
therefore do not meet the formal definition of epigenetic. A more detailed discussion of the 
issues can be found here [4]. 
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Executive summary 
Association of chromatin marks using computational methods. 
 There is a wealth of data on the location of specific histone modifications within the 
genome, generated from high throughput chromatin immunoprecipitation (ChIP) 
studies.  
 Computational methods are now being used on these data to look at the extent of 
overlap and association between individual marks. 
 Clustering of chromatin marks has identified sets of chromatin modifications 
associated with individual genomic features (eg transcription initiation sites, enhancers 
and transcribed sequences).  
 Several sets of modifications have been found associated with each feature suggesting 
either some redundancy within these sets and/or functional variation between related 
sets. 
 Machine learning methods focussed on uncovering connections between two or three 
individual marks has identified a widespread association between active and 
repressive marks.  
 In depth analysis of some of associations has identified some potentially subtle roles 
of individual modifications in regulating gene expression. 
 
Identifying linked modifications using quantitative proteomics  
 Recent advances in mass spectrometry techniques coupled with labelling and/or 
purification are allowing the quantitative analysis of mixtures of peptides.  
 One advantage of this technique is the ability to identify whether multiple 
modifications occur on the same histone molecule. 
 One use of this method has been to determine the extent  of modifications on a 
specific histone has and has shown that only subsets of the potential variation is found 
in vivo. 
 Another approach is to quantify the changes in histone modifications in response to a 
loss of histone modifying enzymes which has provided some hints at mechanisms by 
which those enzymes achieve their functional roles. 
 
Cross-talk in generating chromatin changes 
 Understanding relationships between individual chromatin modifications does not on 
its own provide us mechanistic understanding of the function of those modifications..  
 Understanding the mechanisms will require functional and biochemical approaches. 
 From what we currently know, it appears that many of the chromatin modifications 
promote further modifications by recruiting specific enzymes or complexes that 
recognise one mark and modify another. 
 
 
In eukaryotes, genomic DNA does not exist as a naked molecule, but is wrapped 
around histone proteins to form chromatin. The unit of chromatin is the nucleosome which 
consists of DNA wrapped around a histone octamer consisting of 2 copies each of histone 
H2A, H2B, H3 and H4. Interaction of DNA with histones is structurally important as it 
facilitates the packing of genomic DNA into a cell nucleus. The histone proteins can also be 
post translationally modified at specific residues which provides signals that are recognised 
by proteins which regulate processes (eg transcription) acting upon the underlying DNA 
sequence, The modifications that have been identified on histone proteins include acetylation 
of lysine residues, methylation of lysine and arginine residues and phosphorylation of serine. 
These modifications have been shown to participate in diverse functions including 
transcription, DNA repair, DNA replication and apoptosis. For a detailed discussion of the 
different modifications and their roles in cellular physiology and disease see [5, 6]  
It is becoming clear that such chromatin modifications do not act in isolation but that 
there is cross-talk between individual modifications such that the presence of one 
modification may influence the activity of other modifications (for a comprehensive overview 
of discovery and potential function of combinatorial chromatin modifications see [7]). Cross-
talk between chromatin marks can be manifested in different ways and can result in a positive 
link, one modification enhancing the deposition or activity of another, or a negative outcome, 
one modification inhibiting the deposition or activity of another. Further, such interactions 
can take place in cis, between modifications on the same histone or in trans, between 
modifications on different histones [8, 9]. The molecular mechanism underlying much of the 
currently known interactions relies on the fact that many chromatin modifying proteins exist 
as part of larger complexes that contain proteins that recognise specific chromatin 
modifications (readers) as well as proteins that deposit (writers) or remove (erasers) 
chromatin marks. Such complexes thus have the potential to produce large scale changes to 
the chromatin landscape to which they are recruited. Combinatorial activity is not confined to 
protein complexes as some individual proteins contain domains that can recognise specific 
marks as well as enzyme activities that can modify chromatin. For example the chromatin 
remodelling enzyme Brg1 contains a bromodomain that can recognise and bind to acetylated 
lysine residues as well as an ATPase domain that remodels nucleosome positions [10, 11] 
while the histone methyltransferase G9a can bind  mono- and dimethylated lysine residue via 
a domain containing ankyrin repeats [12] and methylate H3K9 and H3K27 via its 
methyltransferases domain [13-15]. 
 
 
Association of chromatin marks using computational methods. 
The advent of next generation sequencing coupled to chromatin immunoprecipitation 
(ChIP-seq) has allowed researchers to interrogate the locations of specific histone 
modifications across entire genomes. In combination with gene expression data, researchers 
are now in a position to quantify associations of individual marks, not only with each other 
but also with mRNA levels and other features of genes such as promoters, coding regions and 
enhancers. One early breakthrough in this area was the observation that H3K4me1 is found 
enriched and H3K4me3 depleted at enhancer regions and such a chromatin signature was able 
to predict novel enhancer regions [16]. Though they predict enhancer sequences with 
relatively high accuracy, H3K4me levels on their own do not discriminate active enhancers 
from poised enhancers.  More recent work has shown that the presence of H3K27ac correlates 
with active enhancers providing a set of modifications, acting as a signature, by which these 
two enhancer types can be  distinguished [17]. 
 Studies correlating specific chromatin marks with known functional sites are a useful 
way to identify potentially important modifications. An alternative approach is to identify any 
patterns of chromatin modifications occur repeatedly and more often than expected by chance 
throughout the genome which has the advantage that it does not require prior knowledge of 
specific functional sites [18, 19]. Using such an unsupervised approach with genomic location 
data for 9 histone modifications (H3ac, H4ac, H3K9ac, H3K18ac, H3K27ac, H3K4me, 
H3K4me2, H3K4me3 and H3), Hon et al. identify eight chromatin signature patterns [18], 
significantly fewer than the 362,880 potential patterns that arise from 9 independent 
modifications. Given that the number of potential combinations of all known histone 
modifications exceeds the number of nucleosomes in the human body, it is not feasible that 
the entire potential repertoire of chromatin modification patterns could be utilised by the cell. 
This suggests we will only find a subset of the potential modification patterns. In addition 
there is some evidence that, like the triplet code for amino acids, there is redundancy in 
chromatin marks [19, 20]. The individual signatures identified do correlate very well with 
specific functional elements such as known promoters and enhancers suggesting that distinct 
chromatin signatures are associated with distinct functions [18]. Using an expanded set of 21 
histone modifications the same group identified signatures associated with promoters, 
enhancers, insulators and exons in CD4+ T cells [19]. In each case multiple signatures were 
found associated with each feature though whether this is due to redundancy within the 
patterns or reflects subtle functional variation awaits experimental validation. 
Using machine learning methods, on published genome wide Chip-seq data, Xu et al. 
[20] identified 7 monovalent modifications and 16 multivalent (8 bivalent and 8 trivalent) 
marks associated with gene expression. The ChIP approach used to generate the original 
dataset utilised micrococcal nuclease to fragment the genome into single nucleosomes, thus 
individual marks that overlap are presumed to be derived from the same nucleosome. 
However it is possible that individual modifications are present in different cells within the 
population of cells used for the study. Such uncertainties could be resolved by the use 
sequential ChIP to determine if the multiple modifications are indeed present on the same 
nucleosome. One surprising finding of this study is the extent of overlap between apparently 
opposing marks. In Embryonic stem cells many groups have reported the widespread use of 
the bivalent mark consisting of a repressive mark (H3K27me3) and activating mark 
(H3K4me3) to produce a poised state in many genes [21]. Upon differentiation, such bivalent 
marks are resolved so that in differentiated cells a given gene is associated with either 
H3K4me3 or H3K27me3 depending on whether or not it is expressed in the differentiated cell 
[22]. In the study by Xu et al. 8 of the 16 multivalent marks consist of a mixture of activating 
and repressing marks with one mark apparently acting in a dominant way to the other. Such 
ability of one mark to override another appears to some extent to be concentration dependant. 
Gene expression levels associated with the bivalent mark H3K36me3/H3K27me2 are higher 
when the ratio of H3K36me3 to H3K27me2 is high and lower when the ratio is low. There is 
a threshold level of H3K27me2, above which high levels of H3K36me3 do not appear to 
enhance gene expression suggesting H3K27me2 is a dominant mark to H3K36me3 (Figure 
1). In a second bivalent mark studied, H3K36me3/H4R3me2, the positive H3K36me3 mark 
strongly overrides the repressive H4R3me2 [20] suggesting there may be a hierarchy of 
influence among histone modifications (Figure 1). The single mark most strongly associated 
with a repressive effect was found to be the symmetrically methylated arginine H4R3me2. 
The role of H4R3me2, suggested by its association with gene expression and active histone 
marks, is that it is involved in further repressing low to moderately expressed genes [20]. A 
biochemical mechanism underlying H4R3me2 repression has previously been identified 
which involves the recruitment of DNA methyltransferase 3A (DNMT3A, a de novo DNA 
methyltransferase) and couples histone methylation to DNA methylation [23]. Such a subtle 
role for H4R3me2 may go some way to explaining why a previous genome wide study did not 
identify any association of H4R3me2 with either active or silent promoters [24].  
Though genomewide studies generate a lot of data, care should be taken that the 
datasets are truly representative. Assessing the quality of the data can be difficult, though 
some potential problems can be overcome by using multiple reads, a requirement facilitated 
by next generation sequencing approaches. The wealth of genome wide datasets that are 
currently being generated open the door to more sophisticated analyses that should hopefully 
uncover some more of the complexity of interactions and associations between histone 
modifications and provide some clues to their functional roles in regulating gene expression.  
 Identifying linked modifications using quantitative proteomics  
 
One potential limitation of ChIP studies is that it is not possible to know whether two 
modifications occur within the same histone or in different histones within the same 
nucleososme. Another limitation is the specificity of the antibodies used to isolate the 
chromatin fractions – though many antibodies used have been well characterised with respect 
to known modifications problems may arise due to an antibody recognising more than one 
modification or the presence of a second modification masking an antibody binding to its 
epitope [25, 26]. Complementary approaches such as mass spectrometry are thus particularly 
useful because they are not dependant on antibody specificity. Recent advances in proteomic 
technologies have allowed the modification state of histone tails to be interrogated and these 
studies are highlighting some potential functional connections between individual 
modifications (for a review on the use of quantitative mass spectrometry in epigenetic studies 
see [7, 27]). Such studies cannot however be a direct replacement, because unlike ChIP, the 
proteomic approach does not allow the specific modifications identified to be mapped to 
genomic regions, associated with open/closed chromatin or with active/repressed genes and it 
is difficult to look at associations between modifications occurring on different histones. Thus 
any functional consequences of interactions between modifications can only be inferred by 
what we know of the individual component marks. Two groups have used mass spectrometry 
to interrogate the combinations of post translational modifications on histone H4 [28-30]. 
Pesavento et al. used two-dimensional liquid chromatography to separate multiply modified 
forms of Histone H4, obtained from HeLa cells, into fractions which were then individually 
subjected to mass spectrometry analysis [29] while Phanstiel et al. used HPLC to separate 
differentially acetylated H4 peptide fractions from human ES cells and a human fibroblast 
line, IMR90, which were the subjected to mass spectrometry [30]. Pesavento et al. identified 
42 different isoforms of Histone H4 in HeLa cells while Phanstiel et al. identified 72 isoforms 
in ES cells. These differences could be due to different sensitivities, the different ways in 
which histone proteins were purified or due to the different cell types used. In support of the 
latter explanation, Phanstiel et al. identified greater number of modification patterns in the H4 
peptides which contained H3K20me and were multiply acetylated. Overall the ES H4 
peptides were hyperacetylated compared to IMR90 cells and acetylation levels were reduced 
upon ES cell differentiation [30]. The Histone H4 N–terminal region (amino acids 1-20) 
contains 4 lysine residues at positions 5, 8, 12 and 16, which can all be acetylated. Consistent 
with previous ChIP data both studies identified that the levels of acetylation of K16 were the 
highest [29, 30]. Previous data has suggested that K12 is acetylated at the next highest level 
and data from Pesavento et al. was consistent with this idea. However the study by Phanstiel 
et al. showed K5 to be the next most highly acetylated H4 lysine in ES cells. Furthermore the 
ratio of lysine acetylation was found to be affected by the methylation of K20 in HeLa cells 
by Pesavento et al. Indeed in monoacetylated H4 that contains K20me3, all of the acetylation 
is found at K16 leading them to conclude that the presence of K20me increases the likelihood 
of acetylation occurring on at a more proximal lysine [29]. How such an influence is brought 
about is not clear but may for example involve interactions of the K20me with histone 
acetyltransferases, deacetylases or result in a histone tail structure more readily acetylated at 
K16. Also, such a interaction does not seem to occur within ES cells; in H4K20me3 peptides 
monoacetylation marks are found at each of the four lysines in approximately the same ratio 
as found for non-methylated H4 peptides [30]. Both studies did find that H4R3me was only 
present on peptides containing a K20me2 mark suggesting that H4R3 methylation requires 
prior methylation of K20. A connection between H4 acetylation and H4K20me was 
previously identified by Scharf et al. using an in vitro chromatin assembly assay (Figure 1) 
[31]. During DNA replication the newly deposited Histone H4 carries acetylation marks at 
lysine 5 and 12 which are removed within minutes of chromatin formation. Inclusion of H4 
into nucleosomes stimulates the ability of the methyltransferase PR-SET7 to methylate 
H4K20. In turn the H4K20me provides a binding site for an MBT domain containing protein 
and an associated histone deacetylase [31].  These data suggest a pathway whereby newly 
deposited Histone H4 is monomethylated at lysine 20 which then acts as a binding site for a 
deacetylase containing complex and deacetylation of K5 and K12 (Figure 1) [31].  
Clearly the ability to quantify the levels of individual modification patterns is a major 
strength of an MS approach and may uncover associations not predicted by previous analysis. 
For example, previous work has suggested that H4K20me3 is associated with 
heterochromatin formation and whilst overall H4K20me3 is associated with a hypoacetylated 
H4 tail, 30% of the H4 containing K20me3 is also acetylated at K16 in HeLa cells [29], a 
mark not consistent with its proposed role. A potential requirement for H4K20me2, which is 
linked to transcriptionally inactive regions, for deposition of H4R3me, which is linked to 
transcriptionally active regions, is also intriguing. The functional significance of these 
potential interactions awaits experimental interrogation and future work aimed at identifying 
the association of these variants with specific chromatin or genomic features should hopefully 
uncover this. 
A recent proteomic study by Plazas-Mayorca et al. [32] used mass spectrometry of 
purified histone tails from HEK293 cells to identify potential cross-talk between H3K9me and 
other modifications. The authors used siRNA to knock down G9a and Glp1, two histone 
methyltransferases that interact and mono- and di-methylate H3K9 [14] and H3K27 [15, 33], 
in HEK293 cells. Upon knockdown of G9a and Glp1, levels of both H3K9me1 and H3K9me2 
were reduced, the levels of non-methylated H3K9 doubled while levels of H3K9me3 were not 
affected [32]. With respect to modifications at other positions, the level of the repressive mark 
H3K27me2 showed a slight decrease which may reflect the extent to which H3K27 is 
methylated by G9a/Glp1 [15] in HEK293 cells while the levels of H3K36me2 were slightly 
increased. H3K36me2 is associated with transcriptional activation when it is located in the 3’ 
region of genes but with transcriptional repression when found in the coding region [34, 35]. 
Perhaps more significantly the levels of H3K79me2, a mark associated with gene activation, 
approximately doubled suggesting there may be some antagonism between H3K9me2 and 
H3K79me2 [32]. As well as being a substrate for methylation, H3K9 can also be acetylated, a 
mark associated with gene activation. After knockdown of G9a/Glp1, though the levels of 
non-methylated H3K9 increased, there was no significant increase in the levels of acetylation 
at this position. There was however an increase in the levels of acetylation at H3K14, another 
active mark [36, 37], leading the authors to suggest that the presence of H3K9me2 inhibits 
H3K14 acetylation (Figure 1 ) [32]. One caveat to this study is that a study of gene expression 
levels showed that knockdown of G9a/Glp1 led to the altered expression of 5201 genes [32], 
some of which are known to modify chromatin and the altered levels of chromatin modifying 
enzymes could contribute to the changes in histone in response to the loss G9a/Glp1. In a 
similar approach, Pasini et al. [38] used embryonic stem cells lacking the essential polycomb 
repressive complex 2 (PRC2) subunit, Suz12 to investigate the changes resulting from loss of 
PRC2 mediated H3K27me3. In ES cells lacking Suz12, levels of H3K27me2 and H3K27me3 
were reduced and levels of H3K27ac increased about four fold suggesting that one way PRC2 
represses gene activity is by preventing H3K27 acetylation.  
One technical issue with using mass spectrometry is the requirement for purified 
fragments derived from a trypsin digestion of the parent molecule. Young et al. [28] 
developed an automated high throughput method that couples liquid chromatography to 
electron transfer dissociation mass spectrometry. With this approach they were able to 
identify 70 forms of H4 and 200 forms of the histone variant H3.2 and, importantly, examine 
the combinatorial modifications across large peptide fragments [28]. More progress in this 
area should allow for the identification of combinatorial sets of modifications which include 
individual marks that occur some distance from each other. 
 
Cross-talk in generating chromatin changes 
Recent studies described above have begun to use discovery approaches to identify 
combinatorial chromatin marks, though the mechanisms generating these combinations and 
their functional consequence will require more focused biochemical assays. Some 
interactions, both in cis and trans, have been identified using candidate approaches and the 
molecular mechanisms responsible for their generation or underlying their function have been 
ascertained (see table 1). 
 In some cases an order has been assigned to sets of chromatin modifications that are 
made in response to some change within the cell. The first example of cross-talk identified 
involves the ubiquitination of H2BK123 which influences methylation of H3K4 and H3K79 
in yeast (Figure 1) [39, 40]. H2BK123 is ubiquinitinated by the protein Rad6 which provides 
a binding site for Cps35, a subunit of the yeast COMPASS complex. COMPASS also 
contains H3K4 methyltransferase activity and thus, once recruited, results in methylation of 
H3K4 [39, 40]. Cps35 also interacts with the H3K79 methyltransferase Dot1 and 
H2BKl123ub is required for H3K79 methylation [40]. Another example of trans cross-talk is 
provided by the transcription factor REST. REST is a transcriptional repressor associated with 
two protein complexes containing multiple chromatin modifying enzymes [41]. Recruitment 
of REST to chromatin is mediated at least partly by the chromatin remodelling enzyme, Brg1 
and is enhanced by binding of the Brg1 bromodomain to acetylated H4 [42]. The ensuing 
chromatin remodelling enhances the stability of REST:chromatin interaction and leads to 
histone deacetylation by the recruited histone deacetylases. One result of histone 
deacetylation is a stimulation of the histone demethylase enzyme LSD1 and a reduction in 
H3K4 methylation. The levels of the acetylation and methylation are tightly linked in 
chromatin regulated by REST [43-45]. Many of these functional interactions appear to result 
from the substrate specificity of the modifying enzyme, the H3K4 demethylase, LSD1, 
demethylates a non-acetylated template much more readily than an acetylated template [44, 
45] while several of the H3K9 methyltransferases, (SETDB1, G9a/ GLP and SUV39H1) 
cannot bind and methylate histone tails containing H3K4 methylation [46]. Cross-talk is not 
restricted to interactions between histone modifications - biochemical studies have also 
identified cross-talk between hypoacetlyation, H3K9, H3K27 or H4K20 methylation and 
DNA methylation (for a more in depth discussion see [8, 9, 47]). More recently symmetrical 
dimethylation of arginine at H4R3 by the protein arginine methyltransferases PRMT5 has 
been shown to lead to DNA methylation because a domain within DNMT3A binds the 
symmetrically methylated H4R3me2 [23].   
Even though we have likely only scratched the surface of the interactions between 
individual chromatin modifications these studies highlight chromatin as a very dynamic 
entity. Individual modifications are, on their own, likely to have quite subtle effects. A series 
of cascading modifications, on the other hand,  where one change initiates another could 
result in a dramatic shift in the chromatin landscape and facilitate the ability of, for example, 
individual genes to be expressed highly in one cell type but not in another. 
 
Future perspective  
 In the decade since the histone code was first proposed we have made great strides in 
understanding the mechanisms by which the chromatin marks are read and how they are 
written or erased. Clearly there is still much to learn but with the ability to generate large 
datasets using ChIp-seq we can expect to have a much greater understanding of how the 
chromatin landscape relates to specific features within the genome. Using proteomic 
approaches it is currently only possible to correlate modifications within a single peptide. 
Purification of individual nucleosomes carrying a specific modification would be the next 
logical step to try and probe for trans interactions using mass spectrometry. Understanding the 
underlying molecular mechanisms is likely to be more difficult to progress rapidly given the 
requirement for biochemical assays that do not lend themselves well to automation or high 
throughput. We should expect to see more insights into structures of chromatin modifying 
complexes which would hopefully shed light on how isoforms within such complexes alter 
their function and/activity [48, 49]. Though we may not understand entirely how the 
chromatin landscape is sculpted we should hopefully have a good appreciation of what it 
means after another decade of research in the histone code. 
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Figure 1  
A representation of a nucleosome showing some of the in cross-talk between individual marks 
discussed within the text. For clarity only one of each Histone protein is represented in the 
nucleosome and although many of the interactions have been suggested, and are shown, 
between residues within the same nucleosome and/or within the same histone protein this has 
not been proven for all interactions.  
 
